BG96171A - Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат - Google Patents

Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат

Info

Publication number
BG96171A
BG96171A BG096171A BG9617192A BG96171A BG 96171 A BG96171 A BG 96171A BG 096171 A BG096171 A BG 096171A BG 9617192 A BG9617192 A BG 9617192A BG 96171 A BG96171 A BG 96171A
Authority
BG
Bulgaria
Prior art keywords
amidinophenylalaline
derivatives
preparation
application
agents containing
Prior art date
Application number
BG096171A
Other languages
English (en)
Other versions
BG60683B1 (bg
Inventor
Werner Stueber
Gerhard Dickneite
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of BG96171A publication Critical patent/BG96171A/bg
Publication of BG60683B1 publication Critical patent/BG60683B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)

Abstract

Изобретението е приложимо в органичния синтез. Амидофенилаланиновите съединения имат антитромбозна активност, ензимна устойчивост и са добре поносими. Те са с обща формула в която заместителите имат значенията, посочени в описанието. 14 претенции
BG96171A 1991-04-09 1992-04-02 Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат BG60683B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4111394A DE4111394A1 (de) 1991-04-09 1991-04-09 Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
BG96171A true BG96171A (bg) 1993-12-24
BG60683B1 BG60683B1 (bg) 1995-12-29

Family

ID=6429103

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96171A BG60683B1 (bg) 1991-04-09 1992-04-02 Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат

Country Status (28)

Country Link
US (1) US5274098A (bg)
EP (1) EP0508220B1 (bg)
JP (1) JPH0597793A (bg)
KR (1) KR920019738A (bg)
CN (1) CN1067431A (bg)
AT (1) ATE125549T1 (bg)
AU (1) AU650526B2 (bg)
BG (1) BG60683B1 (bg)
BR (1) BR9201253A (bg)
CA (1) CA2065585A1 (bg)
CS (1) CS106492A3 (bg)
DE (2) DE4111394A1 (bg)
DK (1) DK0508220T3 (bg)
ES (1) ES2076595T3 (bg)
FI (1) FI921525A (bg)
GR (1) GR3017107T3 (bg)
HU (1) HUT65359A (bg)
IE (1) IE67347B1 (bg)
IL (1) IL101529A (bg)
MA (1) MA22495A1 (bg)
MX (1) MX9201642A (bg)
NO (1) NO921382L (bg)
NZ (1) NZ242246A (bg)
PL (1) PL294148A1 (bg)
RO (1) RO109197B1 (bg)
TW (1) TW214542B (bg)
UY (1) UY23395A1 (bg)
ZA (1) ZA922535B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4242655A1 (de) * 1992-12-17 1994-06-23 Behringwerke Ag Verwendung von Thrombin-Inhibitoren zur Inhibition okularer Fibrinbildung
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
WO1996005189A1 (de) * 1994-08-09 1996-02-22 Pentapharm Ag Neue inhibitoren vom benzamidintyp
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
DE19517198C1 (de) * 1995-05-11 1996-10-10 Samson Ag Verfahren zur Führung der Hubstellung eines Stellgliedes
US5766932A (en) * 1995-12-20 1998-06-16 Hoechst Marion Roussel, Inc. Process for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisin
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
KR19990074598A (ko) * 1998-03-12 1999-10-05 성재갑 고체상 반응을 이용한 벤즈아미딘 유도체의 신규한 제조방법
SI1288205T1 (sl) 2000-08-18 2011-05-31 Ajinomoto Kk Novi derivati fenilalanina
SI21137A (sl) * 2002-01-24 2003-08-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Derivati azafenilalanina
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
BRPI0418026A (pt) * 2003-12-22 2007-04-17 Ajinomoto Kk derivados de fenilalanina ou sais farmaceuticamente aceitáveis destes, composição farmacêutica, antagonista de alfa4 integrina, e, agente terapêutico ou agente preventivo para doenças
US8410149B2 (en) 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CA2590962A1 (en) * 2004-12-06 2006-06-15 Siga Technologies, Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CN101034257B (zh) * 2007-04-06 2010-09-08 上海复旦天臣新技术有限公司 用于全息记录的感光薄膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028380A (en) * 1974-06-01 1977-06-07 Akzona Incorporated Hydrazino-imidazole derivatives
DD155954B1 (de) * 1981-02-03 1988-11-09 Wagner Guenter Verfahren zur herstellung von n tief alpha arly-bzw. n tief alpha heteroarylsulfonylaminoacylierten amidinophenylalaninamiden
DD235866B1 (de) * 1985-03-29 1988-12-28 Univ Leipzig Verfahren zur herstellung von n alpha (2-naphthyl)-sulfonylaminoacylierten amidinophenylalanisamiden
PT84171B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados das n alfa-aril-sulfonilamiminoacil-p- -amidinofenil-alaninamidas, bem como dos seus derivados de sintese e das composicoes farmaceuticas que os contem
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas

Also Published As

Publication number Publication date
US5274098A (en) 1993-12-28
CA2065585A1 (en) 1992-10-10
HUT65359A (en) 1994-05-02
NO921382D0 (no) 1992-04-08
ZA922535B (en) 1992-11-25
TW214542B (bg) 1993-10-11
AU650526B2 (en) 1994-06-23
MX9201642A (es) 1992-10-01
DE59203006D1 (de) 1995-08-31
PL294148A1 (bg) 1993-02-08
GR3017107T3 (en) 1995-11-30
IL101529A0 (en) 1992-12-30
KR920019738A (ko) 1992-11-19
BG60683B1 (bg) 1995-12-29
NZ242246A (en) 1993-12-23
DE4111394A1 (de) 1992-10-15
BR9201253A (pt) 1992-12-01
UY23395A1 (es) 1992-04-21
HU9201189D0 (en) 1992-07-28
ATE125549T1 (de) 1995-08-15
FI921525A0 (fi) 1992-04-07
IE921123A1 (en) 1992-10-21
DK0508220T3 (da) 1995-11-27
MA22495A1 (fr) 1992-12-31
FI921525A (fi) 1992-10-10
EP0508220A1 (de) 1992-10-14
EP0508220B1 (de) 1995-07-26
CN1067431A (zh) 1992-12-30
NO921382L (no) 1992-10-12
IL101529A (en) 1996-05-14
AU1470392A (en) 1992-10-15
RO109197B1 (ro) 1994-12-30
CS106492A3 (en) 1992-10-14
IE67347B1 (en) 1996-03-20
JPH0597793A (ja) 1993-04-20
ES2076595T3 (es) 1995-11-01

Similar Documents

Publication Publication Date Title
BG96171A (bg) Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат
BG92804A (bg) 4-бензоилизоксазолови производни
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
MY119820A (en) Guanidine mimics as factor xa inhibitors
ATE65994T1 (de) Insektentoetende pyrazoline.
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
TNSN97015A1 (fr) Nouveaux derives de 19-nor-pregnene.
FR2721608B1 (fr) Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
DE3776391D1 (de) Fluessige zubereitungen von 1,2-benzisothiazolin-3-on, ihre herstellung und verwendung.
FR2684103B1 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
EA199900534A1 (ru) Имидазопиридазины
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ATE57933T1 (de) Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.
ATE61360T1 (de) Antioxidierend wirkende verbindungen, ihre herstellung und ihre verwendung.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
DE59108566D1 (de) Heteroarylmethylbenzole-Aromatasehemmer
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.
YU61096A (sh) Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije
EA200000006A1 (ru) Новые производные пентаэритрита, их получение и применение, а также промежуточные соединения для их синтеза
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao